BioMarin Pharmaceutical, Inc. (NASDAQ:BMRN)

CAPS Rating: 4 out of 5

The Company develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions.

Recs

2
Player Avatar navyskindoc (< 20) Submitted: 4/26/2010 11:42:36 PM : Outperform Start Price: $23.18 BMRN Score: +188.77

Good pipeline. Filling niches where big pharma isn't interested in going. Solid front office leadership

Featured Broker Partners


Advertisement